Orphenadrine Citrate Tablet, Extended Release
Product Images NDC 68788-9138

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 68788-9138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Ccdf0ccb 14f9 46c3 Bc8c 84a8b0cb48c8 01)

Chemical structure diagram showing the molecular arrangement of orphenadrine citrate, the active ingredient in the product Orphenadrine Citrate extended-release tablets by Preferred Pharmaceuticals, Inc.*

FDA Label Image

Orphenadrine Citrate Extended Release Tablets 100mg (Ccdf0ccb 14f9 46c3 Bc8c 84a8b0cb48c8 02)

Label of Orphenadrine Citrate Extended-Release Tablets 100 mg, generic for Norflex, manufactured by Lupin Pharmaceuticals, Inc. The label includes dosage form as extended-release tablets, storage instructions, warnings about alcohol use and drowsiness, and space for lot number, batch, and expiration date. Labeler is Preferred Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.